A

Accelerate Diagnostics
D

AXDX

0.71000
USD
0.00
(0.00%)
Market Closed
Volume
5
EPS
0
Div Yield
-
P/E
-0
Market Cap
17,781,114
Related Instruments
A
ADAP
0.05270
(20.79%)
0.30620 USD
B
BEAT
0.02000
(1.01%)
2.00000 USD
G
GH
1.030
(2.43%)
43.490 USD
ILMN
ILMN
3.480
(4.44%)
81.820 USD
ISRG
ISRG
10.91
(2.20%)
507.00 USD
O
OPK
-0.01500
(-0.90%)
1.65500 USD
PODD
PODD
6.05
(2.30%)
269.21 USD
R
RGEN
2.490
(1.94%)
131.030 USD
T
TNDM
0.170
(0.91%)
18.900 USD
V
VCYT
0.610
(2.07%)
30.140 USD
More
News

Title: Accelerate Diagnostics

Sector: Healthcare
Industry: Medical Devices
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.